S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.21 (-1.69%)
MSFT   398.88 (-1.33%)
META   483.13 (-3.72%)
GOOGL   153.17 (-1.82%)
AMZN   174.75 (-2.49%)
TSLA   148.59 (-0.89%)
NVDA   808.23 (-4.54%)
AMD   148.30 (-4.37%)
NIO   3.81 (-4.75%)
BABA   68.50 (-0.55%)
T   16.32 (-0.06%)
F   12.10 (+0.33%)
MU   106.98 (-4.42%)
GE   148.32 (-3.02%)
CGC   7.94 (+1.40%)
DIS   111.40 (-0.92%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   61.81 (-0.47%)
XOM   119.97 (+1.22%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.21 (-1.69%)
MSFT   398.88 (-1.33%)
META   483.13 (-3.72%)
GOOGL   153.17 (-1.82%)
AMZN   174.75 (-2.49%)
TSLA   148.59 (-0.89%)
NVDA   808.23 (-4.54%)
AMD   148.30 (-4.37%)
NIO   3.81 (-4.75%)
BABA   68.50 (-0.55%)
T   16.32 (-0.06%)
F   12.10 (+0.33%)
MU   106.98 (-4.42%)
GE   148.32 (-3.02%)
CGC   7.94 (+1.40%)
DIS   111.40 (-0.92%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   61.81 (-0.47%)
XOM   119.97 (+1.22%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.21 (-1.69%)
MSFT   398.88 (-1.33%)
META   483.13 (-3.72%)
GOOGL   153.17 (-1.82%)
AMZN   174.75 (-2.49%)
TSLA   148.59 (-0.89%)
NVDA   808.23 (-4.54%)
AMD   148.30 (-4.37%)
NIO   3.81 (-4.75%)
BABA   68.50 (-0.55%)
T   16.32 (-0.06%)
F   12.10 (+0.33%)
MU   106.98 (-4.42%)
GE   148.32 (-3.02%)
CGC   7.94 (+1.40%)
DIS   111.40 (-0.92%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   61.81 (-0.47%)
XOM   119.97 (+1.22%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.21 (-1.69%)
MSFT   398.88 (-1.33%)
META   483.13 (-3.72%)
GOOGL   153.17 (-1.82%)
AMZN   174.75 (-2.49%)
TSLA   148.59 (-0.89%)
NVDA   808.23 (-4.54%)
AMD   148.30 (-4.37%)
NIO   3.81 (-4.75%)
BABA   68.50 (-0.55%)
T   16.32 (-0.06%)
F   12.10 (+0.33%)
MU   106.98 (-4.42%)
GE   148.32 (-3.02%)
CGC   7.94 (+1.40%)
DIS   111.40 (-0.92%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   61.81 (-0.47%)
XOM   119.97 (+1.22%)
Free Trial
TSE:MSL

Merus Labs International (MSL) Stock Price, News & Analysis

→ Don’t expose yourself to stocks during the week (From DTI) (Ad)
Free MSL Stock Alerts
Compare
Today's Range
N/A
50-Day Range
C$1.65
▼
C$1.65
52-Week Range
N/A
Volume
21,975 shs
Average Volume
476,228 shs
Market Capitalization
C$193.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
MSL stock logo

About Merus Labs International Stock (TSE:MSL)

Merus Labs International Inc. is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company's products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates. Sintrom is an anticoagulant indicated to treat and prevent thromboembolic diseases. Emselex/Enablex is used in adults to treat overactive bladder syndrome. Surgestone is used to treat women with menstrual irregularities due to ovulation disorder, dysmenorrhea and premenstrual syndrome. Provames is used as hormone replacement therapy in postmenopausal women with symptoms of estrogen deficiency.

MSL Stock News Headlines

April 18, 2024 | americanbankingnews.com
Merus Labs International (TSE:MSL) Earns "Buy" Rating from HC Wainwright
April 18, 2024 | americanbankingnews.com
Research Analysts Issue Forecasts for Merus Labs International Inc.'s Q1 2024 Earnings (TSE:MSL)
April 19, 2024 | Tips4Traders (Ad)
Uncover this 2024 Hidden Gem
Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.
January 10, 2024 | ca.finance.yahoo.com
Albert Labs International Corp. (ABRT.CN)
September 1, 2023 | finance.yahoo.com
Defense Technologies International Corp. (DTII) Expands and Signs PT Lab Sistematika Indonesia as Distributor for SOUTHEAST ASIA
March 19, 2023 | newsweek.com
Global Biosafety Fears Grow Amid Rise in Labs Handling Dangerous Pathogens
February 22, 2023 | finance.yahoo.com
Laboratory Information System Global Market Report 2023
February 19, 2023 | chicago.suntimes.com
Palatine shocks Rolling Meadows, wins MSL title for the first time in 30 years
April 19, 2024 | Tips4Traders (Ad)
Uncover this 2024 Hidden Gem
Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.
January 3, 2023 | finance.yahoo.com
Veterinary Reference Laboratory Global Market Report 2022: Ukraine-Russia War Impact
October 15, 2022 | markets.businessinsider.com
4 Analysts Have This to Say About Merus
September 18, 2022 | investing.com
Albert Labs International Corp (ABRT)
August 29, 2021 | msn.com
Football World Reacts To Bizarre Situation On ESPN
August 27, 2021 | msn.com
Girls Soccer: Worthington Christian Warriors plan to make strides under new coach
August 25, 2021 | msn.com
MSL and aizy spearhead new Danish CS:GO lineup
August 17, 2021 | msn.com
How to unlock a Boost Mobile phone and use it with other carriers
August 12, 2021 | msn.com
Roundup: Lancaster golfers place third in OCC; BC boys win MSL tourney
See More Headlines
Receive MSL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merus Labs International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/27/2024
Today
4/19/2024
Next Earnings (Estimated)
6/04/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Finance
Industry
Major Banks
Sub-Industry
N/A
Current Symbol
TSE:MSL
CUSIP
N/A
CIK
N/A
Web
www.meruslabs.com
Phone
+1-905-7260995
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
117,355,000
Free Float
N/A
Market Cap
C$193.64 million
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover
Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Michael S. Cloutier
    Independent Chairman of the Board
  • Barry Fishman
    Chief Executive Officer, Director
  • Michael Scott Bumby
    Chief Financial Officer
  • Robert McLay
    Vice President - Sales and Marketing
  • Frank Rotmann
    Vice President and Head of European Operations
  • Robert Bloch M.D.
    Director
  • Theresa Sheila Firestone
    Independent Director
  • David D. Guebert CPA
    Independent Director
  • Robert S. Pollock
    Independent Director
  • Timothy G. Sorensen
    Independent Director

Key Competitors

View All Competitors

MSL Stock Analysis - Frequently Asked Questions

Should I buy or sell Merus Labs International stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Merus Labs International in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MSL shares.
View MSL analyst ratings or view top-rated stocks.

When is Merus Labs International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024.
View our MSL earnings forecast.

How were Merus Labs International's earnings last quarter?

Merus Labs International Inc. (TSE:MSL) announced its quarterly earnings results on Wednesday, March, 27th. The specialty pharmaceutical company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.05.

Is Merus Labs International a good dividend stock?

Merus Labs International (TSE:MSL) pays an annual dividend of C$0.04 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of Merus Labs International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merus Labs International investors own include Aurora Cannabis (ACB), (MSLI) (MSLI), ProMetic Life Sciences (PLI), GuestLogix (GXI), Royal Bank of Canada (RY), Sierra Wireless (SWIR), Village Farms International (VFF) and Wheaton Precious Metals (WPM).

How do I buy shares of Merus Labs International?

Shares of MSL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:MSL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
1970’s computer coder issues shocking A.I. warning
TradeSmith